|1.||Boga, Carla: 4 articles (10/2012 - 08/2005)|
|2.||Masotti, Lanfranco: 4 articles (10/2012 - 08/2005)|
|3.||Calonghi, Natalia: 4 articles (10/2012 - 08/2005)|
|4.||Pagnotta, Eleonora: 3 articles (06/2006 - 08/2005)|
|5.||Parolin, Carola: 2 articles (10/2012 - 04/2006)|
|6.||Masotti, L: 2 articles (02/2007 - 01/2004)|
|7.||Brusa, G L: 2 articles (02/2007 - 01/2004)|
|8.||Calonghi, N: 2 articles (02/2007 - 01/2004)|
|9.||Santucci, M A: 2 articles (02/2007 - 01/2004)|
|10.||Pagnotta, E: 2 articles (02/2007 - 01/2004)|
08/01/2005 - "Recent studies have shown that an endogenous lipoperoxidation product, 9-hydroxystearic acid (9-HSA), acts in colon carcinoma cells (HT29) as a growth inhibitor by inducing p21(WAF1) in an immediate-early, p53-independent manner and that p21(WAF1) is required for 9-HSA-mediated growth arrest in HT29 cells. "
|2.||Colonic Neoplasms (Colon Cancer)
01/30/2004 - "Among these, 9-hydroxystearic acid (9-HSA), a primary intermediate of lipid peroxidation, induced a significant arrest in G0/G1 in HT29 colon cancer cells. "
06/01/2006 - "N-methylformamide and 9-hydroxystearic acid: two anti-proliferative and differentiating agents with different modes of action in colon cancer cells."
04/07/2006 - "9-hydroxystearic acid (9-HSA) induces cell proliferation arrest and differentiation in HT29 colon cancer cells by inhibiting histone deacetylase 1 (HDAC1). "
08/01/2005 - "Histone deacetylase 1: a target of 9-hydroxystearic acid in the inhibition of cell growth in human colon cancer."
10/01/2012 - "9-Hydroxystearic acid (9-HSA) belongs to the endogenous lipid peroxidation by-products that decrease in tumors, causing as a consequence the loss of one of the control mechanisms on cell division. "
02/01/2007 - "9-hydroxystearic acid (9-HSA) belongs to the class of endogenous lipid peroxidation by-products that greatly diminish in tumors, causing as a consequence the loss of one of the control mechanisms on cell division. "
01/30/2004 - "9-Hydroxystearic acid upregulates p21(WAF1) in HT29 cancer cells."
|4.||Osteosarcoma (Osteogenic Sarcoma)
|1.||Histone Deacetylase 1
|2.||Epidermal Growth Factor (EGF)